Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Insulin Glargine and Insulin Detemir in Type 1 Diabetes
NCT00271284Phase 3Completed
- Sponsor
- Sanofi
- Start
- Oct 2005
- Primary completion
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin glargine in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Sanofi. Primary endpoint: Variability of Fasting Capillary Blood Glucose Concentration. Started Oct 2005; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00271284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271284.